KURENE FONG: Open Payments
NPI 1912532342 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 61 payments from 14 companies in 2025. Trend: 2023 $2,458 · 2024 $1,597 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $476 |
| Lilly USA, LLC | 10 | $307 |
| Radius Health, Inc. | 5 | $209 |
| Novo Nordisk Inc | 5 | $204 |
| ABBVIE INC. | 5 | $202 |
| Amgen Inc. | 4 | $140 |
| Dexcom, Inc. | 1 | $122 |
| Exact Sciences Corporation | 3 | $96 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| PFIZER INC. | 3 | $56 |
Products named: BREZTRI, UBRELVY, Ozempic, JARDIANCE, AIRSUPRA, FARXIGA, Tymlos, DEXCOM G7 GSS (161).
Industry payments across CA — which companies pay providers there.
